David J. Chang, the Chief Medical Officer of $CABA, bought 8,800 shares of the company on 01-21-2026 for an estimated $19,887. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings of this class of stock by approximately inf%. Following this trade, they now own 8,800 shares of this class of $CABA stock.
$CABA Insider Trading Activity
$CABA insiders have traded $CABA stock on the open market 8 times in the past 6 months. Of those trades, 8 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $CABA stock by insiders over the last 6 months:
- STEVEN NICHTBERGER (President & CEO) purchased 45,000 shares for an estimated $100,777
- SHAWN TOMASELLO purchased 22,725 shares for an estimated $50,322
- STEVE GAVEL (Chief Commercial Officer) purchased 22,170 shares for an estimated $50,215
- MARK SIMON purchased 11,061 shares for an estimated $25,261
- GWENDOLYN BINDER (President, Science & Tech.) purchased 11,312 shares for an estimated $24,763
- DAVID J. CHANG (Chief Medical Officer) purchased 8,800 shares for an estimated $19,887
- MICHAEL GERARD (General Counsel) purchased 6,600 shares for an estimated $14,979
- CATHERINE BOLLARD purchased 4,405 shares for an estimated $9,982
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CABA Hedge Fund Activity
We have seen 36 institutional investors add shares of $CABA stock to their portfolio, and 50 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ALYESKA INVESTMENT GROUP, L.P. removed 3,500,000 shares (-72.9%) from their portfolio in Q3 2025, for an estimated $8,189,999
- JENNISON ASSOCIATES LLC added 2,477,370 shares (+41.2%) to their portfolio in Q3 2025, for an estimated $5,797,045
- JEFFERIES FINANCIAL GROUP INC. removed 1,949,708 shares (-97.6%) from their portfolio in Q3 2025, for an estimated $4,562,316
- ANSON FUNDS MANAGEMENT LP removed 1,822,830 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $4,265,422
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 1,568,701 shares (+23.1%) to their portfolio in Q3 2025, for an estimated $3,670,760
- RENAISSANCE TECHNOLOGIES LLC added 1,213,323 shares (+962.2%) to their portfolio in Q3 2025, for an estimated $2,839,175
- BURKEHILL GLOBAL MANAGEMENT, LP removed 1,200,000 shares (-63.2%) from their portfolio in Q3 2025, for an estimated $2,808,000
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$CABA Analyst Ratings
Wall Street analysts have issued reports on $CABA in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- HC Wainwright & Co. issued a "Buy" rating on 10/10/2025
- Cantor Fitzgerald issued a "Overweight" rating on 09/05/2025
To track analyst ratings and price targets for $CABA, check out Quiver Quantitative's $CABA forecast page.
$CABA Price Targets
Multiple analysts have issued price targets for $CABA recently. We have seen 3 analysts offer price targets for $CABA in the last 6 months, with a median target of $16.0.
Here are some recent targets:
- Josh Schimmer from Cantor Fitzgerald set a target price of $30.0 on 10/31/2025
- Douglas Tsao from HC Wainwright & Co. set a target price of $16.0 on 10/10/2025
- Derek Archila from Wells Fargo set a target price of $2.0 on 08/08/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
